Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-271-5 | CAS number: 105-11-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 13-09-2018 to 26-09-2018
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Guideline study performed under GLP. All relevant validity criteria were met. Test method considered to cover Key Event-1 under OECD 168 (2012) and OECD 255 (2016) and OECD 256 (2016).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- uideline study performed under GLP. All relevant validity criteria were met. Test method considered to cover Key Event-1 under OECD 168 (2012) and OECD 255 (2016) and OECD 256 (2016).
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- p-benzoquinone dioxime
- EC Number:
- 203-271-5
- EC Name:
- p-benzoquinone dioxime
- Cas Number:
- 105-11-3
- Molecular formula:
- C6H6N2O2
- IUPAC Name:
- N-[(1Z,4Z)-4-(hydroxyimino)cyclohexa-2,5-dien-1-ylidene]hydroxylamine
- Test material form:
- solid
- Details on test material:
- - Physical state: Solid
- Storage condition of test material: In refrigerator (2-8°C) container flushed with nitrogen
- Other: Brown powder
Constituent 1
In chemico test system
- Details of test system:
- cysteine peptide, (Ac-RFAACAA-COOH)
- lysine peptide (Ac-RFAAKAACOOH)
- Details on the study design:
- Skin sensitisation (In chemico test system) - Details on study design:
- The study was conducted in accordance with the OECD TG 422C – In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA)
- The study protocol was validated with the proficiency chemicals prescribed in the OECD test guideline 442C. The results of the testing on the proficiency chemicals at the test facility is in the public domain (refer to study references provided in the full study report at the relevant test facility). All ten proficiency chemicals described in OECD TG 442C: Annex 2, were according to the test facility correctly predicted in a study conducted outside the present study. This information is in the public domain.
- Solubility of the test item in an appropriate solvent was assessed before performing the DPRA. An appropriate solvent dissolved the test item completely, i.e. by visual inspection the solution had to be not cloudy nor have noticeable precipitate. The following solvents were evaluated: acetonitrile (ACN), Milli-Q water (MQ), ACN:MQ (1:1, v/v) and isopropanol (IPA). At a concentration of 100 mM, the test item was not soluble in ACN, MQ or ACN:MQ (1:1, v/v), but was soluble in IPA. Therefore, IPA solvent was used to dissolve the test item. Visual inspection of the forming of a clear solution was considered sufficient to ascertain that the test item was dissolved. The test item, positive control and peptide samples were prepared less than 4 hours before starting the incubation of the cysteine (cys) or lysine (lys) reactivity assay, respectively.
- HPLC-PDA (UV) methodology are reported in the full study report.
- Preparation of synthetic peptide solutions [Synthetic Peptide Containing Cysteine (SPCC) and Synthetic Peptide Containing Lysine (SPCL)]
1. Cysteine: A stock solution of 0.667 mM SPCC (0.501 mg SPCC/mL) was prepared by dissolving 10.2 mg of SPCC in 20.36 mL phosphate buffer pH 7.5. The mixture was stirred for 5 minutes followed by 5 minutes sonication. SPCC Reference Control solutions: Three 0.5 mM SPCC reference control (RC) solutions (RCcysA, RCcysB and RCcysC) were prepared in amber vials by mixing 750 µL of the 0.667 mM SPCC stock solution with 250 µL ACN. In addition, a RCcysCIPA sample was included to evaluate the effect of the solvent that was used to dissolve the test item on the Percent Peptide Depletion. The RCcysCIPA sample was prepared by mixing 750 µL of the 0.667 mM SPCC stock solution with 200 µL ACN and 50 µL IPA. The SPCC was subsequently calibrated at multiple concentrations. Co-elution control, test item and positive control samples were also prepared (full details on calibration and sample preparation available in the full study report).
2. Lysine: A stock solution of 0.667 mM SPCL (0.518 mg SPCL/mL) was prepared by dissolving 10.6 mg of SPCL in 20.46 mL of ammonium acetate buffer pH 10.2 followed by stirring for 5 minutes. SPCL Reference Control solutions: Three 0.5 mM SPCL reference control (RC) solutions (RClysA, RClysB and RClysC) were prepared in amber vials by mixing 750 µL of the 0.667 mM SPCL stock solution with 250 µL ACN. In addition, a RClysCIPA sample was included to evaluate the effect of the solvent that was used to dissolve the test item on the Percent Peptide Depletion. The RClysCIPA sample was prepared by mixing 750 µL of the 0.667 mM SPCL stock solution with 250 µL IPA. The SPLC was subsequently calibrated at multiple concentrations. Co-elution control, test item and positive control samples were also prepared (full details on calibration and sample preparation available in the full study report).
- Sample incubations: After preparation, the samples (reference controls, calibration solutions, co-elution control, positive controls and test item samples) were placed in the autosampler in the dark and incubated at 25±2.5°C. The incubation time between placement of the samples in the autosampler and analysis of the first RCcysB- or RClysB-sample was 24.5 hours. The time between the first RCcysB- or RClysB-injection and the last injection of a cysteine or lysine sequence, respectively, did not exceed 30 hours.
- Acceptability criteria:
(i) standard calibration curve(s) are to have an r2 > 0.99. (Actual: SPCC r2 = 0.998 and SPLC r2 = 0.9942)
(ii) mean Percent Peptide Depletion value of the three replicates for the positive control cinnamic aldehyde are to be between 60.8% and 100% for SPCC and between 40.2% and 69.0% for SPCL. (Actual: SPCC 70.4% ± 1.1% and 50.5% ± 3.8%)
(iii) maximum standard deviation (SD) for the positive control replicates are to be <14.9% for the Percent Cysteine Peptide Depletion and <11.6% for the Percent Lysine Peptide Depletion. (Actual SPCC PC : SD = 1.1% and SPCL PC : SD = 3.8%)
(iv) mean peptide concentration of Reference Controls A is to be 0.50 ± 0.05 mM. (Actual: Cysteine A, C and CIPA reference controls: 0.514 ± 0.022 mM, 0.504 ± 0.002 mM and 0.489 ± 0.022 mM ; Lysine A, C and CIPA reference controls: 0.515 ± 0.015 mM, 0.529 ± 0.009 mM and 0.523 ± 0.012 mM, respectively).
(v) Coefficient of Variation (CV) of peptide areas for the nine Reference Controls B and C in ACN are to be <15.0%. (Actual: Cysteine Reference Controls B and C : CoV = 2.3% ; Lysine: Reference Controls B and C was 3.2%)
Other: Within the Cysteine Reactivity Assay: In the CC sample no peak at 220 nm was observed at the retention time of SPCC, however, at 258 nm a peak was observed. This demonstrated that at a wavelength of 220 nm, which is used to determine the SPCC depletion, there was no interference of the test item with SPCC. It was not possible to calculate the mean SPCC A220/A258 area ratio since the test item displayed high reactivity towards SPCC. Overall, it was concluded that the test item did not interfere with SPCC at a wavelength of 220 nm for quantitative analysis purposes. Within the Lysine Reactivity Assay: In the CC sample no peak at 220 nm was observed at the retention time of SPCL whereas a small response at 258 nm was observed. This demonstrated that at a wavelength of 220 nm, which is used to determine the SPCL depletion, there was no interference of the test item with SPCL. For the A-lys samples, the mean SPCL A220/A258 area ratio was 6.13. This was outside the 15.16-18.52 range, however, since the test item did not interfere with SPCL at 220 nm, it can be concluded that the responses at a wavelength of 220 nm were suitable for quantitative analysis purposes.
All acceptance criteria were fulfilled for the PC (cinnamic aldehyde).
All relevant acceptability criteria were met.
- Synthetic peptides:
Cysteine- containing peptide: Ac-RFAACAA-COOH (MW=750.9) – full details on source provided in full study report.
Lysine-containing peptide: Ac-RFAAKAA-COOH (MW=775.9) – full details on source provided in full study report.
- Controls:
Positive control (PC): Cinnamic aldehyde (CAS 104-55-2; 99.1%) – full details on source provided in full study report.
Negative control (NC): Vehicle = Isopropanol
Evaluation of results: In accordance with OECD TG 442C – Table 1.
Test item reactivity was determined by mean peptide depletion and was rated as high, moderate, low, or minimal:
Mean peptide depletion [%] Reactivity
> 42.47 high reactivity (Positive)
> 22.62 < 42.47 moderate reactivity (Positive)
> 6.38 < 22.62 low reactivity (Positive)
< 6.38 minimal reactivity (Negative) - Vehicle / solvent:
- isopropanol
- Positive control:
- cinnamic aldehyde
Results and discussion
- Positive control results:
- - All PC acceptability criteria were met.
- PC CYS-peptide depletion (mean): 70.4% ± 1.1% (high reactivity)
- PC LYS-peptide depletion (mean): 50.5% ± 3.8% (moderate reactivity)
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- mean
- Parameter:
- mean cystein depletion
- Value:
- 100 %
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: HIGH REACTIVITY CLASS
- Remarks:
- n = 3 ; See 'any other information on results incl. tables' for further information
- Key result
- Run / experiment:
- mean
- Parameter:
- mean lysine depletion
- Value:
- 0.6 %
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- n = 3 ; Test item appears to have no or minimal reactivity to Lys peptide ; See 'any other information on results incl. tables' for further information
- Outcome of the prediction model:
- high reactivity [in chemico]
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: None reported.
DEMONSTRATION OF TECHNICAL PROFICIENCY: The study protocol was validated with the proficiency chemicals prescribed in the OECD test guideline 442C. The results of the testing on the proficiency chemicals at the test facility is in the public domain (refer to study references provided in the full study report at the relevant test facility). All ten proficiency chemicals described in OECD TG 442C: Annex 2, were according to the test facility correctly predicted in a study conducted outside the present study. This information is in the public domain.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: All criteria met.
- Acceptance criteria met for positive control: All criteria met.
- Acceptance criteria met for variability between replicate measurements: All criteria met.
- Range of historical values if different from the ones specified in the test guideline: Not applicable.
- Acceptability criteria:
(i) standard calibration curve(s) are to have an r2 > 0.99. (Actual: SPCC r2 = 0.998 and SPLC r2 = 0.9942)
(ii) mean Percent Peptide Depletion value of the three replicates for the positive control cinnamic aldehyde are to be between 60.8% and 100% for SPCC and between 40.2% and 69.0% for SPCL. (Actual: SPCC 70.4% ± 1.1% and 50.5% ± 3.8%)
(iii) maximum standard deviation (SD) for the positive control replicates are to be <14.9% for the Percent Cysteine Peptide Depletion and <11.6% for the Percent Lysine Peptide Depletion. (Actual SPCC PC : SD = 1.1% and SPCL PC : SD = 3.8%)
(iv) mean peptide concentration of Reference Controls A is to be 0.50 ± 0.05 mM. (Actual: Cysteine A, C and CIPA reference controls: 0.514 ± 0.022 mM, 0.504 ± 0.002 mM and 0.489 ± 0.022 mM ; Lysine A, C and CIPA reference controls: 0.515 ± 0.015 mM, 0.529 ± 0.009 mM and 0.523 ± 0.012 mM, respectively).
(v) Coefficient of Variation (CV) of peptide areas for the nine Reference Controls B and C in ACN are to be <15.0%. (Actual: Cysteine Reference Controls B and C : CoV = 2.3% ; Lysine: Reference Controls B and C was 3.2%)
Other: Within the Cysteine Reactivity Assay: In the CC sample no peak at 220 nm was observed at the retention time of SPCC, however, at 258 nm a peak was observed. This demonstrated that at a wavelength of 220 nm, which is used to determine the SPCC depletion, there was no interference of the test item with SPCC. It was not possible to calculate the mean SPCC A220/A258 area ratio since the test item displayed high reactivity towards SPCC. Overall, it was concluded that the test item did not interfere with SPCC at a wavelength of 220 nm for quantitative analysis purposes. Within the Lysine Reactivity Assay: In the CC sample no peak at 220 nm was observed at the retention time of SPCL whereas a small response at 258 nm was observed. This demonstrated that at a wavelength of 220 nm, which is used to determine the SPCL depletion, there was no interference of the test item with SPCL. For the A-lys samples, the mean SPCL A220/A258 area ratio was 6.13. This was outside the 15.16-18.52 range, however, since the test item did not interfere with SPCL at 220 nm, it can be concluded that the responses at a wavelength of 220 nm were suitable for quantitative analysis purposes. All acceptance criteria were fulfilled for the PC (cinnamic aldehyde).
All relevant acceptability criteria were met.
Any other information on results incl. tables
Table 1.0 – Acceptability of the DPRA
|
Cysteine reactivity assay |
Lysine reactivity assay |
||
Acceptability criteria |
Results for SPCC |
Acceptability criteria |
Results for SPCL |
|
Correlation coefficient (r2) standard calibration curve |
>0.99 |
0.998 |
>0.99 |
0.994 |
Mean peptide concentration RC-A samples (mM) |
0.50 ± 0.05 |
0.514 ± 0.022 |
0.50 ± 0.05 |
0.515 ± 0.015 |
Mean peptide concentration RC-C samples (mM) |
0.50 ± 0.05 |
0.504 ± 0.002 |
0.50 ± 0.05 |
0.529 ± 0.009 |
Mean peptide concentration RC-CIPA samples (mM) |
0.50 ± 0.05 |
0.489 ± 0.022 |
0.50 ± 0.05 |
0.523 ± 0.012 |
CV (%) for RC samples B and C |
<15.0 |
2.3 |
<15.0 |
3.2 |
Mean peptide depletion PC (cinnamic aldehyde) (%) |
60.8-100 |
70.4 |
40.2-69.0 |
50.5 |
SD of peptide depletion PC (cinnamic aldehyde) (%) |
<14.9 |
1.1 |
<11.6 |
3.8 |
SD of peptide depletion for the test item (%) |
<14.9 |
0.0 |
<11.6 |
0.5 |
Where: RC = Reference Control; CV = Coefficient of Variation; SD = Standard Deviation
Table 2.0 – Results of the DPRA with the test item
SPCC depletion (CYSTEINE) |
SPCL depletion (LYSINE) |
Mean of SPCC and SPCL depletion |
|||
Mean |
± SD |
Mean |
± SD |
||
Test item |
100.0% |
±0.0% |
0.6% |
±0.5% |
50.3% |
Applicant's summary and conclusion
- Interpretation of results:
- other: The test item gave a positive in DPRA and was classified in the “high reactivity class” using the Cysteine 1:10 / Lysine 1:50 prediction model. The result will be considered within a weight of evidence assessment for Classification and Labelling purposes
- Conclusions:
- Under the condition of this study, the test item is considered to be sensitising to the skin. The test item indicated a positive in the DPRA and was classified in the “high reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Executive summary:
The study was performed to the OECD TG 442C in chemico Direct peptide reactivity Assay (DPRA) guideline under GLP. The test item was assessed for reactivity to model synthetic peptides containing either cysteine (SPCC) or lysine (SPCL). After incubation of the test item with either SPCC or SPCL, the relative peptide concentration was determined by High-Performance Liquid Chromatography (HPLC) with gradient elution and photodiode array (PDA) detection at 220 nm and 258 nm. SPCC and SPCL Percent Depletion Values were calculated and used in a prediction model which allows assigning the test item to one of four reactivity classes used to support the discrimination between sensitizers and non-sensitizers. Isopropanol (IPA) was found to be an appropriate solvent to dissolve the test item. Upon preparation of the SPCC and SPCL test item samples, no precipitate or phase separation was observed in any of the samples. After incubation of the SPCC and SPCL test item samples, a precipitate was observed. In the cysteine reactivity assay the test item showed 100.0% SPCC depletion while in the lysine reactivity assay the test item showed 0.6% SPCL depletion. The mean of the SPCC and SPCL depletion was 50.3% and as a result the test item was considered to be positive in the DPRA and classified in the “high reactivity class” when using the Cysteine 1:10 / Lysine 1:50 prediction model. All relevant test acceptability criteria were met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.